{"disease":{"id":"therapeutic-opioid-induced-constipation","name":"Therapeutic opioid induced constipation","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":5,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"methylnaltrexone","indication_name":"Therapeutic opioid induced constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Relistor","generic_name":"METHYLNALTREXONE","company_name":"Salix Pharms","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":69,"revenue":"400","mechanism":"Relistor works by blocking opioid receptors in the gut to alleviate constipation."},{"drug_id":"naldemedine","indication_name":"Therapeutic opioid induced constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Symproic","generic_name":"NALDEMEDINE","company_name":"Bdsi","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":75,"revenue":null,"mechanism":"Symproic works by blocking the mu-type opioid receptor, which is responsible for slowing down bowel movements."},{"drug_id":"naltrexon","indication_name":"Therapeutic opioid induced constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naltrexon","company_name":"Institute of Liver and Biliary Sciences, India","drug_phase":"marketed","molecular_target":"Neuronal acetylcholine receptor subunit alpha-7, Cytochrome P450 2D6, Delta-type opioid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"movantik","indication_name":"Therapeutic opioid induced constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Movantik","company_name":"AstraZeneca","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"naloxegol","indication_name":"Therapeutic opioid induced constipation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Movantik","generic_name":"NALOXEGOL","company_name":"Averitas","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":65,"revenue":null,"mechanism":"Movantik works by blocking the mu-type opioid receptor, which is responsible for the constipating effects of opioids."}],"pipeline":[],"offLabel":[],"totalMarketed":5,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03355807","title":"Use of MgSO4 for Pain After Bariatric Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Yeditepe University Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}